Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 1 pseudogene 24 (HMGB1P24)
- Target
- HMGB1P24
- Molecular classification
- Other (Processed pseudogene)
01
Overview
High mobility group box 1 pseudogene 24 (HMGB1P24) is a processed human pseudogene related to the parental gene high mobility group box 1 (HMGB1). Like other pseudogenes, HMGB1P24 is not considered a protein-coding gene; it is a genomic sequence resembling HMGB1 but typically does not produce a functional protein. There is no evidence that HMGB1P24 is a therapeutic target, nor is there functional information linking it directly to disease, drug interactions, or clinical biomarkers. While some pseudogenes can exert regulatory effects or act as competitive endogenous RNAs, there is currently no data to support such a function for HMGB1P24. Therefore, "HMGB1P24" is not a therapeutic target, and there is nothing to suggest aberrant spelling or identity, but it is not relevant as a functional drug or disease target.
- Other names
- High mobility group box 1 pseudogene 24HMGB1P24
02
Mechanism of action
Not applicable
03
Biological functions
None (no confirmed protein function); as a pseudogene, it is not known to have direct protein-coding function or characterized regulatory roles.
04
Disease associations
None specifically described for HMGB1P24; pseudogenes in general may be implicated in regulatory networks or as competitive endogenous RNAs in some cases, but no direct evidence for HMGB1P24
05
Safety considerations
None
06
Interacting drugs
None
07
Biomarkers
None
Beyond the preview
Go deeper on High mobility group box 1 pseudogene 24 (HMGB1P24).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on High mobility group box 1 pseudogene 24 (HMGB1P24).